Cargando…

Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells

Enhancer of zeste homolog 2 (EZH2) plays a crucial role in embryonic and somatic stem cells for their proliferation and differentiation. However, the roles and underlying mechanisms of EZH2 in prostate cancer stem cells (PCSCs) remain unknown. This study aimed to investigate the effects of EZH2 on P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kuiqing, Liu, Cheng, Zhou, Bangfen, Bi, Liangkuan, Huang, Hai, Lin, Tianxin, Xu, Kewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709767/ https://www.ncbi.nlm.nih.gov/pubmed/23739676 http://dx.doi.org/10.3390/ijms140611981

Ejemplares similares

ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010)

Calcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
por: Wang, Jing-Huan, et al.
Publicado: (2008)

Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells
por: Li, Wei, et al.
Publicado: (2018)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: Zhang, Xianqing, et al.
Publicado: (2018)

Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells
por: Cui, Luwei, et al.
Publicado: (2019)

Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
por: Yu, Pan, et al.
Publicado: (2017)

AB179. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells
por: Hu, Fengzhan, et al.
Publicado: (2015)

CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells
por: Wei, Chaogang, et al.
Publicado: (2018)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.
por: Wolf, D. A., et al.
Publicado: (1991)

Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment
por: Sieh, Shirly, et al.
Publicado: (2012)

EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
por: CHEN, PEIJIE, et al.
Publicado: (2014)

MiR‐145 affected the circular RNA expression in prostate cancer LNCaP cells
por: He, Jin‐Hua, et al.
Publicado: (2018)

Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
por: Sohn, Hong Moon, et al.
Publicado: (2019)

URG11 promotes proliferation and induced apoptosis of LNCaP cells
por: Sun, Chenmin, et al.
Publicado: (2019)

Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP Cells
por: Alizadeh Zarei, M., et al.
Publicado: (2017)

Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-Beta or Carboxyl Esterase on the Growth of LNCaP Prostate Cancer Cells
por: Yi, Bo-Rim, et al.
Publicado: (2012)

Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells
por: IGUCHI, KAZUHIRO, et al.
Publicado: (2014)

Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells
por: Sun, Xiaojuan, et al.
Publicado: (2010)

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.
por: Culig, Z., et al.
Publicado: (1998)

Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach
por: Bainbridge, Matthew N, et al.
Publicado: (2006)

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells
por: Abdulah, Rizky, et al.
Publicado: (2009)

Correction: Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment
por: Sieh, Shirly, et al.
Publicado: (2013)

Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G(1) to S Phase
por: Murthy, Shalini, et al.
Publicado: (2013)

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib
por: WANG, HUAQIAN, et al.
Publicado: (2014)

MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells
por: Nam, Robert K., et al.
Publicado: (2018)

Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines
por: Seim, Inge, et al.
Publicado: (2017)

The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
por: Morell, C, et al.
Publicado: (2016)

Effect of miR-200c on proliferation, invasion and apoptosis of prostate cancer LNCaP cells
por: Lin, Jianxi, et al.
Publicado: (2019)

A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells
por: Briggs, Erica M., et al.
Publicado: (2019)

Stromal Fibroblasts Counteract the Caveolin-1-Dependent Radiation Response of LNCaP Prostate Carcinoma Cells
por: Wittka, Alina, et al.
Publicado: (2022)

Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells
por: Lee, Myoung-Sun, et al.
Publicado: (2016)

Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells
por: Lee, Chan-Hee, et al.
Publicado: (2010)

Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival
por: Giordano, Francesca, et al.
Publicado: (2019)

A Walnut-Enriched Diet Reduces the Growth of LNCaP Human Prostate Cancer Xenografts in Nude Mice
por: Reiter, Russel J., et al.
Publicado: (2013)

HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling
por: Kim, Young-Rang, et al.
Publicado: (2010)

LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
por: Romanuik, Tammy L, et al.
Publicado: (2010)

Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
por: Suominen, Mari I., et al.
Publicado: (2023)

Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3
por: Krycer, James Robert, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fqftnul63pk6nlb9jdbpc3th28